FR2189034A2 - - Google Patents
Info
- Publication number
- FR2189034A2 FR2189034A2 FR7321743A FR7321743A FR2189034A2 FR 2189034 A2 FR2189034 A2 FR 2189034A2 FR 7321743 A FR7321743 A FR 7321743A FR 7321743 A FR7321743 A FR 7321743A FR 2189034 A2 FR2189034 A2 FR 2189034A2
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2811872A GB1434919A (en) | 1972-06-15 | 1972-06-15 | 3alpha-hydroxy androstanes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2189034A2 true FR2189034A2 (cg-RX-API-DMAC10.html) | 1974-01-25 |
| FR2189034B2 FR2189034B2 (cg-RX-API-DMAC10.html) | 1977-01-21 |
Family
ID=10270562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7321743A Expired FR2189034B2 (cg-RX-API-DMAC10.html) | 1972-06-15 | 1973-06-14 |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE800899R (cg-RX-API-DMAC10.html) |
| CA (1) | CA1040619A (cg-RX-API-DMAC10.html) |
| DE (1) | DE2330342A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK136157B (cg-RX-API-DMAC10.html) |
| FR (1) | FR2189034B2 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1434919A (cg-RX-API-DMAC10.html) |
| LU (1) | LU67790A1 (cg-RX-API-DMAC10.html) |
| NL (1) | NL7308267A (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA734037B (cg-RX-API-DMAC10.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3498725T (pt) | 2013-04-17 | 2021-09-09 | Sage Therapeutics Inc | Esteroides c21-n-pirazolilo 19-nor c3,3-dissubstituídos para uso em terapia |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| RU2700264C2 (ru) | 2013-04-17 | 2019-09-16 | Сейдж Терапьютикс, Инк. | 19-нор нейроактивные стероиды и способы их применения |
| US9725481B2 (en) | 2013-04-17 | 2017-08-08 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof |
| PL3021852T3 (pl) | 2013-07-19 | 2021-07-05 | Sage Therapeutics, Inc. | Neuroaktywne steroidy, kompozycje i ich zastosowania |
| RU2696585C2 (ru) | 2013-08-23 | 2019-08-05 | Сейдж Терапьютикс, Инк. | Нейроактивные стероиды, их композиции и применение |
| WO2015195962A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| CN118344424A (zh) | 2014-10-16 | 2024-07-16 | 萨奇治疗股份有限公司 | 靶向cns障碍的组合物和方法 |
| LT3206493T (lt) | 2014-10-16 | 2020-08-25 | Sage Therapeutics, Inc. | Kompozicijos ir būdai, skirti cns sutrikimams gydyti |
| EP3224269B1 (en) | 2014-11-27 | 2020-02-26 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| JP6745274B2 (ja) | 2015-01-26 | 2020-08-26 | セージ セラピューティクス， インコーポレイテッド | Ｃｎｓ障害を処置するための組成物および方法 |
| EP3258939B1 (en) | 2015-02-20 | 2022-09-07 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| ES2992037T3 (es) | 2016-07-11 | 2024-12-05 | Sage Therapeutics Inc | Esteroides neuroactivos sustituidos en C7, C12 y C16 y sus procedimientos de utilización |
| NZ790226A (en) | 2016-07-11 | 2025-08-29 | Sage Therapeutics Inc | C17, C20, and C21 substituted neuroactive steroids and their methods of use |
| JP7670626B2 (ja) | 2019-05-31 | 2025-04-30 | セージ セラピューティクス， インコーポレイテッド | 神経刺激性ステロイド及びその組成物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH273860A (de) * | 1942-04-25 | 1951-02-28 | Nv Organon | Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe. |
| FR2118123A1 (cg-RX-API-DMAC10.html) * | 1970-12-17 | 1972-07-28 | Glaxo Lab Ltd | |
| FR2118117A1 (cg-RX-API-DMAC10.html) * | 1970-12-17 | 1972-07-28 | Glaxo Lab Ltd |
-
1972
- 1972-06-15 GB GB2811872A patent/GB1434919A/en not_active Expired
-
1973
- 1973-06-14 BE BE132254A patent/BE800899R/xx active
- 1973-06-14 NL NL7308267A patent/NL7308267A/xx not_active Application Discontinuation
- 1973-06-14 FR FR7321743A patent/FR2189034B2/fr not_active Expired
- 1973-06-14 DK DK328673AA patent/DK136157B/da unknown
- 1973-06-14 CA CA174,050A patent/CA1040619A/en not_active Expired
- 1973-06-14 ZA ZA734037A patent/ZA734037B/xx unknown
- 1973-06-14 LU LU67790A patent/LU67790A1/xx unknown
- 1973-06-14 DE DE2330342A patent/DE2330342A1/de not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH273860A (de) * | 1942-04-25 | 1951-02-28 | Nv Organon | Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe. |
| FR2118123A1 (cg-RX-API-DMAC10.html) * | 1970-12-17 | 1972-07-28 | Glaxo Lab Ltd | |
| FR2118117A1 (cg-RX-API-DMAC10.html) * | 1970-12-17 | 1972-07-28 | Glaxo Lab Ltd |
Also Published As
| Publication number | Publication date |
|---|---|
| BE800899R (fr) | 1973-12-14 |
| LU67790A1 (cg-RX-API-DMAC10.html) | 1973-08-16 |
| GB1434919A (en) | 1976-05-12 |
| NL7308267A (cg-RX-API-DMAC10.html) | 1973-12-18 |
| ZA734037B (en) | 1974-05-29 |
| DE2330342A1 (de) | 1974-01-17 |
| FR2189034B2 (cg-RX-API-DMAC10.html) | 1977-01-21 |
| AU5693773A (en) | 1974-12-19 |
| DK136157C (cg-RX-API-DMAC10.html) | 1978-01-23 |
| CA1040619A (en) | 1978-10-17 |
| DK136157B (da) | 1977-08-22 |